This caught my attention because the story mentioned Myriad Genetics -- a
proteomics company I've been following. Hitachi are also involved. Oracle
is supplying computing power. Ellison has shown strong interest in biotech
and has endowed his foundation with plenty of money for far-sighted biotech
research. (Alas, from what I hear, those who administer the foundation are
not as far-sighted as Ellison.) Here's an excerpt for those interested in
the convergence of IT and biotech, and for those looking for a possible
investment (Myriad is well off last year's levels and has a good technology
platform).
>Ellison, the nation's second-richest man, is enthralled with biotech's
>potential. He has invested some of his own money in biotech start-ups and
>in February told a conference of Oracle customers he would seek out a
>career in the biotechnology industry if he were just starting out in
>business today.
http://www.msnbc.com/news/554860.asp?0nm=B16U
Onward!
Max
_______________________________________________________
Max More, Ph.D.
max@maxmore.com or more@extropy.org
www.maxmore.com
President, Extropy Institute. www.extropy.org
Senior Content Architect, ManyWorlds Inc.: www.manyworlds.com
Chair, Extro-5: Shaping Things to Come, www.extropy.org/ex5/extro5.htm
_______________________________________________________
This archive was generated by hypermail 2b30 : Mon May 28 2001 - 09:59:44 MDT